Inhibiting mTOR can have profound effects on cancer cells. mTOR inhibitors, such as rapamycin and its analogs (rapalogs), can reduce cell proliferation, induce cell cycle arrest, and promote apoptosis. These inhibitors can also interfere with the tumor microenvironment, reducing angiogenesis and altering immune responses.
